Devicor Medical Products, Inc.

Mammotome is a global breast care company specializing in diagnostic and surgical solutions for breast cancer detection and treatment. The company manufactures vacuum-assisted breast biopsy systems, stereotactic biopsy devices, MR-guided biopsy platforms, and surgical marker navigation systems. Product portfolio includes the Mammotome PrimaTM MR System (in-room, vacuum-assisted MR breast biopsy), Mammotome RevolveTM and RevolveTM ST stereotactic biopsy systems, Mammotome DualCoreTM and Elite systems, Pintuition® surgical marker navigation system, Neoprobe® GDS gamma detection system, and comprehensive biopsy site markers (HydroMARKTM Plus, standard markers). The company serves 60 countries with 550+ associates across 9 global locations. Mammotome holds FDA clearances for its MR biopsy systems and markers, and Health Canada approval for the Pintuition® System. As a Danaher-owned company, Mammotome integrates advanced imaging compatibility and procedural efficiency into products designed for radiologists, surgeons, and pathologists in hospital and outpatient diagnostic centers.